These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mechanisms of sarcomagenesis. Matushansky I; Maki RG Hematol Oncol Clin North Am; 2005 Jun; 19(3):427-49, v. PubMed ID: 15939190 [TBL] [Abstract][Full Text] [Related]
5. Oncogenesis by retroviruses: old and new paradigms. Maeda N; Fan H; Yoshikai Y Rev Med Virol; 2008; 18(6):387-405. PubMed ID: 18729235 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of dendritic cell vaccines in sarcoma of the extremities. Yu Z; Ren P; Zhang X; Zhang T; Ma B Expert Rev Anticancer Ther; 2009 Aug; 9(8):1065-71. PubMed ID: 19671026 [TBL] [Abstract][Full Text] [Related]
7. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system. D'Angelo E; Spagnoli LG; Prat J Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555 [TBL] [Abstract][Full Text] [Related]
8. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
9. A spatially and temporally restricted mouse model of soft tissue sarcoma. Kirsch DG; Dinulescu DM; Miller JB; Grimm J; Santiago PM; Young NP; Nielsen GP; Quade BJ; Chaber CJ; Schultz CP; Takeuchi O; Bronson RT; Crowley D; Korsmeyer SJ; Yoon SS; Hornicek FJ; Weissleder R; Jacks T Nat Med; 2007 Aug; 13(8):992-7. PubMed ID: 17676052 [TBL] [Abstract][Full Text] [Related]
13. Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET. Riggi N; Cironi L; Suvà ML; Stamenkovic I J Pathol; 2007 Sep; 213(1):4-20. PubMed ID: 17691072 [TBL] [Abstract][Full Text] [Related]
14. High expression of neuropeptide Y1 receptors in ewing sarcoma tumors. Körner M; Waser B; Reubi JC Clin Cancer Res; 2008 Aug; 14(16):5043-9. PubMed ID: 18698022 [TBL] [Abstract][Full Text] [Related]
15. Sarcomas: genetics, signalling, and cellular origins. Part 2: TET-independent fusion proteins and receptor tyrosine kinase mutations. Suvà ML; Cironi L; Riggi N; Stamenkovic I J Pathol; 2007 Oct; 213(2):117-30. PubMed ID: 17703479 [TBL] [Abstract][Full Text] [Related]
16. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers. Sinkovics JG; Horvath JC Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757 [TBL] [Abstract][Full Text] [Related]
17. Undifferentiated sarcoma: does it exist? A clinicopathologic study of 7 pediatric cases and review of literature. Alaggio R; Bisogno G; Rosato A; Ninfo V; Coffin CM Hum Pathol; 2009 Nov; 40(11):1600-10. PubMed ID: 19647855 [TBL] [Abstract][Full Text] [Related]
18. Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma. Rouleau C; Curiel M; Weber W; Smale R; Kurtzberg L; Mascarello J; Berger C; Wallar G; Bagley R; Honma N; Hasegawa K; Ishida I; Kataoka S; Thurberg BL; Mehraein K; Horten B; Miller G; Teicher BA Clin Cancer Res; 2008 Nov; 14(22):7223-36. PubMed ID: 19010839 [TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase expression in high grade soft tissue sarcomas. Alford SH; Vrana MS; Waite L; Heim-Hall J; Sylvia VL; Williams RP Oncol Rep; 2007 Dec; 18(6):1529-36. PubMed ID: 17982640 [TBL] [Abstract][Full Text] [Related]
20. HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan. Kitano S; Kageyama S; Nagata Y; Miyahara Y; Hiasa A; Naota H; Okumura S; Imai H; Shiraishi T; Masuya M; Nishikawa M; Sunamoto J; Akiyoshi K; Kanematsu T; Scott AM; Murphy R; Hoffman EW; Old LJ; Shiku H Clin Cancer Res; 2006 Dec; 12(24):7397-405. PubMed ID: 17189412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]